Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Simoens S; KU Leuven Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium.; Toumi M
Subjects: Drug Costs*; Humans ; United States
-
Source:
Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2024 Apr; Vol. 24 (4), pp. 477-486. Date of Electronic Publication: 2024 Feb 01.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
-
Authors :
Kaló Z; Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary.; Syreon Research Institute, Budapest, Hungary.
Subjects: Drug Costs* ; Technology, Pharmaceutical*; Humans
-
Source:
Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2024 Feb; Vol. 24 (2), pp. 181-187. Date of Electronic Publication: 2024 Jan 25.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
-
Authors :
Savova A; Faculty of Pharmacy, Medical University of Sofias, Sofia, Bulgaria.; National council of prices and reimbursement of medicines, Sofia, Bulgaria.
Subjects: Drug Costs* ; Insurance*; Humans
-
Source:
Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2024 Feb; Vol. 24 (2), pp. 189-202. Date of Electronic Publication: 2024 Jan 25.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
-
Authors :
Ollendorf DA; Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research & Health Policy Studies, Tufts Medical Center, Boston, MA, USA.
Subjects: Technology Assessment, Biomedical* ; Drug Costs*; Humans
-
Source:
Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2024 Jan; Vol. 24 (1), pp. 11-13. Date of Electronic Publication: 2024 Jan 18.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
-
Authors :
Tachkov K; Medical University of Sofia, Faculty of Pharmacy, Sofia, Bulgaria.; Savova A
Subjects: Drug Costs* ; Health Services Accessibility*; Humans
-
Source:
Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2023 Jul-Dec; Vol. 23 (6), pp. 597-606. Date of Electronic Publication: 2023 Apr 17.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
-
Authors :
Takami A; Market Access, Public Affairs & Patient Experience, Japan Pharma Business Unit, Takeda Pharmaceutical Company Limited, Tokyo, Japan.; Department of Health Economics and Outcomes Research, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
Subjects: Drug Costs*; Humans ; Japan
-
Source:
Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2023 Jul-Dec; Vol. 23 (7), pp. 749-759. Date of Electronic Publication: 2023 Jun 20.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
-
Authors :
Quinn C; Tufts Medical Center, Center for Biomedical Innovation NEWDIGS, Boston, MA, USA.; Ciarametaro M
Subjects: Medicaid* ; Drug Costs*; United States
-
Source:
Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2023 Jun; Vol. 23 (5), pp. 535-546. Date of Electronic Publication: 2023 Mar 29.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
-
Authors :
Petrou P; Senior Officer, Health Insurance Organisation, Nicosia, Cyprus.; University of Nicosia, Department of Life and Health Sciences, School of Pharmacy, Pharmacoepidemiology-Pharmacovigilance, Nicosia, Cyprus.
Subjects: Amyloidosis*/Amyloidosis*/Amyloidosis*/drug therapy ; Amyloidosis*/Amyloidosis*/Amyloidosis*/economics ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/economics
-
Source:
Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2023 Mar; Vol. 23 (3), pp. 345-351. Date of Electronic Publication: 2023 Feb 12.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
-
Authors :
Dintsios CM; Institute for Health Services Research and Health Economics, Centre for Health and Society, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.; Institute for Health Services Research and Health Economics, German Diabetes Center at the Heinrich-Heine-University, Leibniz-Center for Diabetes Research, Düsseldorf, Germany.
Subjects: Drug Costs*; Costs and Cost Analysis ; Germany
-
Source:
Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2022 Mar; Vol. 22 (2), pp. 283-297. Date of Electronic Publication: 2021 Jul 12.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101132257 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
Record details
